Haijun Han

Dr. Haijun Han

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in The Journal of Chemical Thermodynamics
Verified
Journal Article
Closed access
LGLijiang Guo
Lijiang Guo
HHHaijun Han
Haijun Han
ODOuyang Dong
Ouyang Dong
YYYan Yao
Yan Yao

6 May 2013 in Journal of Chemical & Engineering Data
Verified
Journal Article
Closed access
HZHongyan Zhou
Hongyan Zhou
DZDewen Zeng
Dewen Zeng
HHHaijun Han
Haijun Han
ODOuyang Dong
Ouyang Dong
DLDongdong Li
Dongdong Li
YYYan Yao
Yan Yao

13 April 2018 in Journal of Chemical & Engineering Data
Verified
Journal Article
Closed access
HHHaijun Han
Haijun Han
XJXiang Ji
Xiang Ji
JMJunjie Ma
Junjie Ma
ZXZhifeng Xu
Zhifeng Xu
LGLijiang Guo
Lijiang Guo
YYYan Yao
Yan Yao

6 October 2017 in Journal of Chemical & Engineering Data
Verified
Journal Article
Closed access
HHHaijun Han
Haijun Han
LGLijiang Guo
Lijiang Guo
DLDongdong Li
Dongdong Li
YYYan Yao
Yan Yao

8 October 2024 in Bioconjugate Chemistry
Verified
Journal Article
Open access
JWJuntao Wang
Juntao Wang
RJRuiqin Jia
Ruiqin Jia
WWWubo Wan
Wubo Wan
HHHaijun Han
Haijun Han
GWGuoying Wang
Guoying Wang
JLJia Li
Jia Li
Inflammation within the brain is a hallmark of a wide range of brain diseases. The complex role of inflammatory processes in these conditions suggests that neuroinflammation could be a valuable therapeutic target. While several promising anti-inflammatory agents have been identified, their clinical application in brain diseases is often hampered by the inability to cross the blood-brain barrier (BBB) and reach therapeutically effective concentrations at the pathological sites. This limitation highlights the urgent need for effective BBB-penetrating drug delivery systems designed to target brain inflammation. This review critically examines the recent advances over the past five years in drug delivery strategies aimed at mitigating brain inflammation in Alzheimer's disease and ischemic stroke─two of the leading causes of death and disability worldwide. Additionally, we address the key challenges in this field, offering insights into future directions for targeting neuroinflammation in the treatment of brain diseases.

5 October 2022 in Coatings
Verified
Journal Article
Open access
PDF file
HHHaijun Han
Haijun Han
HZHongyan Zhou
Hongyan Zhou
ODOuyang Dong
Ouyang Dong
JMJunjie Ma
Junjie Ma
An integrated solar heating system with a new type of phase change material (PCM), solar collectors and test building were developed. The exothermal and endothermal behaviors of the PCM were determined, and the stability and comfort of the solar heating system were researched. The integrated solar heating system was operated on the test building heating for one heating period, and the temperature of heating rooms, the outdoors, and the contrast rooms were recorded and collected by a data acquisition system. The collected temperature data indicated that the integrated solar heating system with PCM could produce heating stability and continuity; the average temperature of the heating rooms using PCM was 4.6 °C higher than the contrast rooms, which did not use PCM. Taking 16 °C as the lowest standard room temperature, the integrated solar heating system could save approximately 45% of energy during one heating period. The successful development of an integrated solar heating system, coupled with phase change materials and solar collectors for building heating will lay a solid foundation for achieving the goals of building energy conservation and “carbon peaking and carbon neutrality”.